Actively Recruiting
Randomized Trial Comparing VES-0-D Gel Versus Standard Care for Mild to Moderate Diabetic Foot Ulcers Over 8 Weeks
Led by Flen Health · Updated on 2026-09-03
64
Participants Needed
8
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of VES-0-D, an investigational wound gel, in treating mild to moderate Diabetic Foot Ulcers DFU. The study aims to compare how well VES-0-D supports wound healing compared to standard wound treatment over an 8-week period. It also investigates wound characteristics relevant to healing and monitors any side effects at the application site. Participants will receive either VES-0-D gel or standard care wound dressings applied every 3 to 4 days for up to 8 weeks or until the wound closes. Applications may be done at home or in the clinic. Weekly clinic visits will be scheduled for assessments and checkups during treatment. Throughout the study, participants will keep a diary of their wound care and any symptoms. Researchers will monitor wound area reduction and use the Bates-Jensen Wound Assessment Tool to evaluate healing progress. Safety data, including any treatment-related adverse events, will also be collected from enrollment through the end of treatment.
CONDITIONS
Brief Title
A Study Comparing an Investigational Wound Gel With Standard Treatment for Mild to Moderate Diabetic Foot Ulcers
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here